About: Accelovance (United States)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Accelovance (United States) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

company in Rockville, United States

Attributes	Values
rdf:type	Item
description	americká firma (cs) bedrijf uit Verenigde Staten van Amerika (nl) company in Rockville, United States (en)
rdfs:label	Accelovance (fr) Accelovance (United States) (en)
skos:prefLabel	Accelovance (fr) Accelovance (United States) (en)
name	Accelovance (fr) Accelovance (United States) (en)
ROR ID	wds:Q30269437-FD001FEE-D0D4-4F9B-B738-91FEBB802EF7
ROR ID	04qm2hz97
instance of	wds:Q30269437-E2FF658E-4673-487C-BBF3-0335616635ED
instance of	business
country	wds:Q30269437-91667D54-2319-4B90-9A47-BF0ED6F97439
country	United States of America
inception	wds:Q30269437-F8259F0E-0E94-4FEB-9D6D-6BA30196BDCE
inception	2004-01-01 00:00:00Z (xsd:dateTime)
headquarters location	wds:Q30269437-EB0A4A74-A4DE-4544-B1FA-DE6AF6DEFEF8
headquarters location	Rockville
Crunchbase organization ID	wds:Q30269437-C14E64F0-200A-4F23-BCF4-04E078B550BF
official website	wds:Q30269437-CD4896BB-2A6C-41BC-A82A-FFEC3DCA22C6
Crunchbase organization ID	accelovance
official website	http://www.accelovance.com/
GRID ID	wds:Q30269437-BE6AD940-0689-4D7F-BDC6-82074A566A0D
GRID ID	grid.476859.1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30269437
is research site of	A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years A/H5N1/LT Dose Ranging Study A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults Evaluation of Low Source of Signal in SCOUT DS A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms A Study to Evaluate the Effects of LCI699 on Safety and Efficacy in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain Pandemic Influenza Plasmid DNA Vaccines (Needle-Free) Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001 Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers Pandemic Influenza Plasmid DNA Vaccines (Needle) One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens) Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain Screening for Early Evidence of Diabetes Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary Reverse Genetic H9N2 Influenza Vaccine Study in Adults
is research site of	wds:Q65368636-AF94AD0B-66F0-4F1E-85B4-A65F324A5801 wds:Q65379205-26446029-38A9-4969-A0E2-622C6403AC72 wds:Q63334100-FBC7ECFA-A1BF-48BF-80B4-A8E01B1BE51C wds:Q64675531-3AC7EA42-D43F-4D88-82A8-7C0200640DFB wds:Q63843940-C72CEB68-E0D8-4064-99F9-6A44C8AD3DFD wds:Q63832046-E0FFC705-3FE6-4191-A6E9-284CDF10FB01 wds:Q63334793-1984500E-DE3B-4CF8-96DD-877B60429EA1 wds:Q64188580-9BB05018-7211-4DA4-A2DD-365AD5841352 wds:Q64695622-6D9EE8F6-1D39-4D43-A004-17B44A461CED wds:Q65473886-ACB9B556-F865-4DEC-BDA5-62777A4C09C8 wds:Q64350898-DF95B3EC-D880-4297-A5F3-790C52581603 wds:Q65391547-ECDDCCB6-80FA-4690-B3E9-46FFE39F1CF4 wds:Q64044146-0E0EE361-E9D9-4563-8550-80AD09548DA3 wds:Q65381298-0AA2A834-539C-45D4-9A1F-C18E7FCFBDB5 wds:Q63807094-EA107741-DFE3-42F8-965C-48532EE60C97 wds:Q64352152-6DE46DCC-C57C-45D8-B4A9-8D4C4EFCF67D wds:Q64041074-07298B1E-A7AF-454D-A585-8600A0C827AE wds:Q65542001-454D1519-6A53-437D-9092-62EFE88B456D wds:Q65382492-4CA42B5C-42ED-480A-B473-A0C440F8EE31 wds:Q65391040-31910474-90E8-4ED2-81CE-3795BC082C27 wds:Q65473250-DC449A47-C6FD-4791-BB8E-D47407269649 wds:Q64723649-C1A0E5A9-BD44-4D3E-9D1D-1D8B2D77CA97 wds:Q66025935-58A34926-D1D2-4ABD-8AEB-1C7EDB407E18 wds:Q64723473-8ED656CC-9CBA-4F74-8BB3-B9C3AA844592 wds:Q63813978-5B012D9A-B56E-447E-8A80-B00965A9C268 wds:Q61713082-0FCC5774-9F31-41DB-919C-239823A4134F wds:Q61974963-06381D83-4065-4753-9C7C-A1CAE09B4CB6 wds:Q65382567-44850A22-9082-4833-9416-209A28DA6B0B wds:Q63817195-86BF09E1-666E-4B6F-9406-E33948362EAD wds:Q63817285-4D26EBDC-9EC6-44C3-A5B0-7560EB71C87F wds:Q61921530-846DF5CB-FDCF-4EB3-B53E-338C3E2394AA wds:Q61924380-F634F9B9-605B-4793-B4D9-6B79EF006086 wds:Q64655628-6A2A135E-8416-4739-9A02-340D539A37E2 wds:Q63319575-8C4A6B01-58F1-45C7-829C-1FEB0B7F6933 wds:Q63336485-9460C784-3C15-4115-ADB2-0C67586503E5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software